Effect of dapagliflozin in patients with heart failure
| Autor: | Joshua Au Yeung, Teck K Khong |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty law.invention chemistry.chemical_compound Glucosides law Diabetes Mellitus Medicine Humans Pharmacology (medical) In patient Dapagliflozin Benzhydryl Compounds Sodium-Glucose Transporter 2 Inhibitors Aged Heart Failure Ejection fraction Clinical pharmacology business.industry General surgery General Medicine Middle Aged medicine.disease Associate editor Hospitalization chemistry Heart failure Female Kidney Diseases business |
| Zdroj: | Drug and therapeutics bulletin. 59(6) |
| ISSN: | 1755-5248 |
| Popis: | Commentary on: McMurray JJV, Solomon SD, Inzucchi SE, et al Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995-2008. Commentary by: Dr Joshua Au Yeunga, Clinical Pharmacology, St Thomas' Hospital, London, UK and Dr Teck Khong, Clinical Pharmacology, St George's, University of London, UK. Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George's, University of London, UK. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|